RemSleep Holdings Inc.

Name: RemSleep Holdings Inc. standardized financial statements, quarterly
Creator: Listed

RMSLOTCCIK 1412126IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$4.4k, Q4 FY2025

Operating income−$36.3k, Q2 FY2026

Net income−$103.5k, Q2 FY2026

RemSleep Holdings Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	51.9	7.5	57.9	27.6	37.3	(5.6)	not reported	4.8	7.5	4.4	not reported	not reported
Cost of revenue	$k	49.9	787	13.6	5.9	58.6	21.1	not reported	0.6	0.0	12.1	not reported	not reported
Gross profit	$k	2.0	(779)	44.3	21.7	(21.3)	(26.6)	not reported	4.2	7.4	(7.6)	not reported	not reported
Research and development	$k	13.9	205	22.2	132	40.8	(9.4)	17.2	1.5	0.0	not reported	not reported	not reported
Operating income	$k	(271)	(1,058)	(124)	(297)	(194)	(178)	(131)	(133)	(2,283)	(221)	(231)	(36.3)
Interest expense	$k	0.0	6.7	2.6	32.9	64.4	17.8	76.3	144	130	38.0	51.3	32.6
Income tax	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$k	(270)	(1,058)	(253)	(226)	(278)	(322)	(85.5)	(288)	(2,312)	(335)	(290)	(103)
Diluted EPS	$ per share	0.00	not reported	0.00	0.00	0.00	not reported	0.00	0.00	0.00	not reported	0.00	not reported
Basic EPS	$ per share	0.00	not reported	0.00	0.00	0.00	not reported	0.00	0.00	0.00	not reported	0.00	not reported

Balance sheet

Cash and equivalents$88.0k, Q1 FY2026

Shareholders' equity−$280.9k, Q2 FY2026

RemSleep Holdings Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$k	904	719	731	699	535	463	507	416	344	215	88.0	not reported
Current assets	$k	1,838	836	844	805	598	492	526	437	373	265	161	79.3
Total assets	$k	2,268	1,206	1,160	1,066	810	592	605	542	464	340	224	154
Current liabilities	$k	192	232	467	494	176	255	354	385	202	300	342	397
Total liabilities	$k	279	276	481	494	176	255	354	402	215	308	346	435
Long-term debt	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$k	1,989	931	678	573	634	337	251	140	249	32.1	(123)	(281)

Cash flow

Operating cash flow−$241.8k, Q2 FY2026

Capital expenditure$51.0k, Q4 FY2024

RemSleep Holdings Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(170)	(174)	(113)	(152)	(272)	(145)	(110)	(141)	(122)	(129)	(177)	(242)
Capital expenditure	$k	7.5	11.7	not reported	not reported	not reported	51.0	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)1.69bn, Q1 FY2026

RemSleep Holdings Inc., shares, quarterly
Line item	Unit	Q2 FY20222022-06-30	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31
Diluted shares (weighted)	m shares	1,426	1,462	1,462	1,462	1,462	1,462	1,472	1,511	1,526	1,544	1,577	1,690

Shares outstanding: 1.74bn at Jun 30, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.